Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Security class unavailable · CUSIP: 690469101

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,828,065
Percent of class
9.6900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-018479
Form type
SC 13G
Filer
Ovid Therapeutics Inc.
CIK
CIK 1636651
Filed
Feb 10, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub